FDA Drug Safety Podcasts
Avsnitt

FDA adds Boxed Warning for increased risk of severe hypocalcemia in patients with advanced chronic kidney disease taking osteoporosis medicine Prolia (denosumab)

FDA Drug Safety Podcasts
Dela

Listen to FDA Drug Safety Podcast titled, FDA adds Boxed Warning for increased risk of severe hypocalcemia in patients with advanced chronic kidney disease taking osteoporosis medicine Prolia (denosumab).

Rss Apple Podcaster
Podden och tillhörande omslagsbild på den här sidan tillhör U.S. Food and Drug Administration, Center for Drug Evaluation and Research. Innehållet i podden är skapat av U.S. Food and Drug Administration, Center for Drug Evaluation and Research och inte av, eller tillsammans med, Poddtoppen.